Drug Approval | April 20, 2026
Aurobindo Pharma bags USFDA nod for Glycerol Phenylbutyrate Oral Liquid
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
The launch coincides with IBS Awareness Month in April
Marking three years of the National Diagnostics Catapult (NDxC), the conclave launched the Impact Report and unveiled environmental surveillance kits
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
The aim is to bolster healthcare delivery in a region increasingly burdened by chronic disease
One Health-based surveillance model to focus on bird sanctuaries and high-risk human populations
Subscribe To Our Newsletter & Stay Updated
